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Endemic pemphigus foliaceus (PF), also known as Fogo Sel-
vagem (FS), is an organ-specific autoimmune disease me-
diated by autoantibodies. These autoantibodies are disease 
specific, predominantly restricted to the IgG4 subclass, and 
pathogenic, as demonstrated by passive transfer studies. In 
contrast to pemphigus vulgaris, neonatal skin disease does not 
appear to occur in babies born to mothers with non-endemic 
PF or FS. In the present study we have examined 19 mother / 
neonate pairs where the mother had documented FS. 
Mothers and neonates were examined soon after delivery and 
tested by immunofluorescent (IF) techniques for FS autoan-
tibodies either in circulation (mothers' sera or babies' cord 
blood) or bound to the neonatal epidermis. All neonates in-
FOgO Selvagem (FS) is the endemic form of pemphigus foliaceus (PF), reported since the beginning of the cen-tury in certain. states of Brazil [1] and recently in Colom-bia [2] . It is thought to be precipitated by an environmen-tal factor [1]. The disease shares similar clinical and 
immunopathologic features with the non-endemic form ofPF seen 
in the rest of the world [3]. For example, PF and FS patients possess 
disease-specific autoantibodies [4,5] that are pathogenic by passive 
transfer studies [6] and are predominantly restricted to the IgG4 
subclass [7]. Furthermore, Fab' fragments of FS IgG are also patho-
genic, suggesting that the epidermal antigen(s) they recognize be-
long(s) to the family of cell adhesion molecules [8]. The mecha-
nisms by which FS autoantibodies cause epidermal disease remain 
unknown. 
Pemphigus vulgaris (PV) and PF or FS are bullous disorders with 
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Abbreviations: 
C-section: Cesarian section 
DG1: desmoglein 1 
FITC: fluorescein isothiocyanate 
FS: Fogo Selvagem 
ICS: intercellular spaces 
IF: immunofluorescence 
PF: pemphigus foliaceus 
PV: pemphigus vulgaris 
cluded in this study were born with normal skin. Twelve 
biopsies from 17 neonates showed negative direct IF using 
both FITC-antihuman IgG or monoclonal anti-IgG subclass 
antibodies . In five biopsies the epidermal ICS of the babies 
showed weak staining. In 10 of the 19 cord sera tested, FS 
IgG autoantibodies were undetectable; in nine, these autoan-
tibodies were present in low titers « 1 : 40). The sera of the 
mothers showed higher titers ofFS autoantibodies, and IgG4 
was the predominant IgG subclass autoantibodies . It appears 
that human placenta may modulate the expression of disease 
in the newborn by operating as a "biologic immunoadsor-
bent" of pathogenic autoantibodies.] Invest Dermatol99:78 -
82, 1992 
unique and distinctive features. PV is characterized by oral and 
cutaneous vesicles and/or bulla that on histologic examination 
show suprabasilar acantholysis and preserved basal cell-dermal ad-
herence. These patients possess pathogenic antiepithelial autoanti-
bodies [9] directed against a 130-kD epidermal antigen [10]. If 
steroid or immunosuppressive therapy ofPV patients is delayed, the 
vesicles and erosions may gradually become confluent and general-
ized, and the mortality of these patients is high. In contrast, PF or FS 
are characterized by superficial epidermal vesicles and/or bullae and 
an absence of oral lesions. The epidermal vesicles are located be-
neath the stratum corneum and the antiepidermal autoantibodies 
recognize a desmosomal glycoprotein named desmoglein 1 (DG-1) 
[11]. PF and FS show a less aggressive course than PV. 
It is well established that female PV patients with active disease 
who can carry a pregnancy to term deliver babies with a transient 
neonatal PV [12-16]. Neonatal PV is presumably precipitated by 
the transplacental passage of pathogenic anti-epidermal autoanti-
bodies. Contrary to this observation, it has been reported that preg-
nant patients with PF and FS deliver babies with normal skin 
[17,1 8]. Experimental data to explain these observations are not 
available. Therefore, the purpose of this study was to evaluate the 
IgG autoantibody profile in 19 FS mothers and their newborn 
babies. We found that all newborns from mothers with FS exhibited 
normal skin. Furthermore, these babies had low or no titers of 
autoantibodies in umbilical cord serum as compared with their 
mothers, who showed higher titers of serum autoantibodies. The 
predominant IgG subclass ofFS autoantibodies in these patients was 
IgG4. 
MATERIALS AND METHODS 
Patient Selection Nineteen FS mother/newborn pairs were in-
cluded in this study. The diagnosis of FS was established in all 
mothers before they became pregnant by clinical, histologic, and 
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immunologic criteria. The diagnosis and follow-up of patients dur-
mg pregnancy and delivery was carried out by dermatologists from 
endemic areas or by the leading author of this paper (Rosicler 
Rocha-Alvarez) . These patients were inhabitants of FS-endemic 
areas in the Brazilian states of Goias, Tocantins, Minas Gerais, Sao 
Paulo, Parana, Mato Grosso, and Brasilia. 
The activity and extent of FS in mothers and neonates were 
scored on the day of delivery. FS was classified as previously re-
pOrted [3]. Sixteen of 19 of the patients included in this study 
exhibited skin lesions typical of FS. Three patients were in com-
plete remission induced by steroid therapy. Blood samples were 
collected from all mothers during delivery and from the umbili-
cal cord of all babies. The serum was obtained by centrifugation 
and stored at -20°C until tested. Following appropriate con-
sent, 3-mm punch biopsies were obtained from 17 neonates and 
placed in Michel's transport medium [19]. Sera were also obtained 
from unaffected individuals living in endemic areas and used as 
Controls. 
Monoclonal Antibodies The isolation and extensive subclass 
and allotypic specificity evaluations for each monoclonal has been 
prevIOusly described [7,20] . The following murine monoclonal anti-
bodies to each of the four human IgG subclasses were utilized: 
HP6001 for IgGl (Calbiochem, La Jolla, CA); HP6014 for IgG2, 
HP6050 for IgG3, and HP6025 for IgG4 (Miles Scientific, Naper-
ville, IL). Each of the four monoclonals was obtained as an ascite 
preparation and used at a dilution of 1 : 5000. 
Itntnunofluorescence Techniques Indirect immunofluores-
cence (IF) techniques were performed using human skin cryosec-
tlons as previously described [21,22]. The bound IgG subclass au-
toantibodies were detected using murine monoclonal antihuman 
Ig.G-subclass-specific antibodies (see above) . Final incubation was 
With a sheep fluorescein isothiocynate (FITC)-conjugated anti-
rnouse IgG (Cappel, West Chester, PA). The sections were exam-
Ined With a Nikon epifluorescent microscope . Each of the sera was 
titrated to the endpoint for each IgG subclass. 
Direct IF studies were performed using cryosections of skin from 
neonates and mothers. A minimum of three sections were incubated 
with IgG-subclass _ specific mouse antihuman monoclonal antibod-T (1: 5000). The bound monoclonal antibody was detected by 
~:ee~ FITC-conjugated anti mouse IgG serum. The intensity of the 
action was scored from - to +++. 
RESULTS 
. ~.Wborn Babies From FS Mothers Showed Normal 
d tn As shown in Table I, one baby died on the second day after 
e livery. This newborn exhibited features of Down's syndrome and 
rnu tlple congenital defects (baby 1), the remainder of the babies 
'k.:re healthy, and all, including baby 1, showed perfectly normal 
s 111. Two FS mothers had two consecutive pregnancies delivering 
borrnal neonates (pairs 5 and 15, and 8 and 14). From the 17 skin 
dlopsles from neonates available for the study, 12 showed negative 
I~ect IF findings using both FITC-anti-human IgG or monoclo-
nf al~tlbodies against IgG subclasses. In five biopsies (from neonates ~ .$alrs 1, 2, 3, 10, and 11), there was a weak staining of the 
bPI e~rnal ICS. The corresponding cord sera for these four positive 
a~~psle~ showed low titers of FS autoantibodies (1 : lOin babies 1, 3 
11, 1: 20111 baby 2) or were negative (baby 10). 
~thers with FS Show Higher Titers of FS Autoantibodies 
FS an Neonates To facilitate the presentation and comparison of 
19 autoantibody titers in mothers and neonates, we have divided the 
l' b7other/neonate pairs into three groups. Group 1 is presented in r: e II and includes mother sera with FS autoantibody titers be-
rn ehn 1: 160 to 1 : 320. Group 2 is shown in Table III and includes 1'~bl ers with .FS autoantibody titers of 1 : 80. Group 3 is shown in 
e IV and mcludes mothers with FS autoantibody titers of 1: 40 
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or lower. Information about FS autoantibodies bound to neonatal 
epidermis is also shown in these three tables. It is clearly shown in all 
three groups of mother/neonate pairs that the titers ofFS autoanti-
bodies as detected with FITC class-specific anti-human IgG were 
much higher in maternal sera than in cord sera. In nine of the cord 
sera, FS autoantibodies were detected in lower titers (1 : 40 in baby 7, 
1: 20 in babies 2 and 13, and 1: 10 in babies 1,3,5,11,14, and 18) . A 
positive staining of neonatal epidermal ICS by direct IF does not 
correlate with positive titers of autoantibodies in the baby cord sera, 
i.e., some babies showed positive direct IF but negative cord sero-
logy or vice versa. 
The distribution ofFS autoantibody activity in each IgG subclass 
in the sera of mothers and neonates are also presented in Tables 
I - IV. In 10 of 19 babies' cord sera, there was no FS autoantibody 
activity; in six babies the titer of IgG4 autoantibodies was 1: 10 
(babies 1, 3, 5, 11, 14, and 18); in two the titers were 1 : 20 (babies 2 
and 13); and in one the titer was 1: 40 (baby 7). In three mothers 
with elevated titers ofIgG4 FS autoantibodies, there were low titers 
of IgG 1 and IgG2 autoantibodies (mothers of pairs 3, 6, and 11); 
however, these antibodies were not detected in the babies' cord 
serum. 
Control sera (over 500) from donors living in endemic and non-
endemic areas of FS showed negative results by indirect IF tech-
niques using human skin substrate and FITC-antihuman IgG or 
monoclonal antibodies against human IgG subclasses. 
DISCUSSION 
The normal development of a fetus during pregnancy in an immun-
ocompetent mother represents one of the mysteries of immunol-
ogy. The maternal immune system appears to passively or actively 
ignore the presence of the developing fetus except in a few occasions 
when the mother becomes sensitized to fetal antigens. In these rare 
instances the mother produces pathogenic antibodies that may reach 
the fetus and cause disease, e.g., Rh or ABO hemolytic disease of the 
newborn [23] and neonatal alloimmune thrombocytopenia [24]. In 
physiologic states, transplacental passage of maternal antibacterial 
and antiviral antibodies to the fetus will protect the newborn against 
undesirable infections during the first few months of life [25]. 
The passive transfers of tissue-specific autoantibodies to experi-
mental animals have reproduced the respective organ-specific dis-
ease in myasthenia gravis [26], PV [9], endemic PF or FS [6-8], and 
Goodpasture's syndrome [27]. These experimental animal models 
strongly support the pathogenic role of these autoantibodies in me-
diating the respective human disease. 
Pregnant women suffering autoimlJlune disease have been re-
ported to deliver babies with a spectrum of clinical syndromes due to 
the transplacental passage of pathogenic autoantibodies. These syn-
dromes constitute "experiments of nature" of passive transfer ex-
periments carried out in laboratory animals. For example, mothers 
with SLE having Ro autoantibodies in their sera have delivered 
babies with neonatal lupus [28] . Neonatal lupus is characterized by 
cutaneous lesions and frequent cardiac conduction defects, which 
are thought to be produced by maternal Ro autoantibodies that have 
reached the fetal circulation and target tissues (29]. Similarly, herpes 
gestationis (HG) is a cutaneous autoimmune disease that occurs in 
the last trimester of pregnancy and has been associated, on a few 
occasions, with a transient skin eruption in the newborn [30] and 
HG factor in cord serum [31]. 
On the contrary, babies born to mothers with well documented 
PV or myasthenia gravis or autoimmune thyroid disease are likely to 
develop either neonatal PV (12-16], neonatal myasthenia gravis 
[32-37], or signs of neonatal thyroid dysfunction [38,39] . It has 
been postulated that maternal autoantibodies may reach the babies' 
circulation and cause transient disease in the epidermis, the muscle, 
or the thyroid gland, respectively. In PV, the correlation of autoan-
tibody titers and disease activity in the mother and the newborn 
appear to correlate fairly well. This correlation is not seen in myas-
thenia gravis, where only 12% of the newborns may show clinical 
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Table I. Clinical and Serologic Features of Mothers with Fogo Selva gem and Their Newborn Babies 
Mother/Neonatal Pairs Indirect IF Direct IF 
Pair Number Age Race Diagnosis Whole IgG IgG1 IgG2 IgG3 IgG4 Whole IgG IgG4 
1 FPA 48 Black FS,generalized 1:320 1:320 ++ +++ 
Newborn F, Down's syndrome < 1: 10 1: 10 + nd 
C-section. Dead 2d day 
2GA 24 White FS,generalized 1:160 1:320 ++ ++ 
Newborn F, normal 1:10 1:20 + + 
3 TJ 30 White FS,generalized 1:80 1 :20 1:320 ++ +++ 
Newborn F, normal 1:10 + 
4 SJ 39 Mulato FS,generalized 1:80 1:160 ++ ++ 
Newborn F, normal 
C-section 
5CJA-l 31 White FS (remission) < 1: 10 1:20 nd nd 
Newborn M, normal 1:10 nd nd 
6 ELS 26 White FS,generalized 1: 320 1: 20 1:10 1:160 ++ +++ 
Newborn F, normal nd nd 
C-section 
7 NSR 17 White FS,generalized 1:80 1 : 80 ++ nd 
Newborn M, normal 1: 40 1:40 nd 
8DRA-1 23 White FS,localized 1:80 1:80 + + 
Newborn F, normal 
9 MAJ 25 Black FS,generalized 1:80 1:80 ++ ++ 
Newborn M, normal 
10ARM FS,generalized 1: 40 1:40 + ++ 
Newborn F, normal + nd 
11 SJO 42 White FS,generalized 1:160 1 :20 1:320 ++ +++ 
Newborn F, normal 
12 LM 28 White FS,localized 1:20 
Newborn M, normal 
13 EAA 18 White FS,generalized 1 :40 
Newborn F, normal 
C-section 
14DRA-2 25 White FS,localized 1:80 
Newborn F, normal 
C-section 
15 CJA-2 33 White FS,localized 1:40 
Newborn F, normal 
16 MNS 22 White FS,localized 1:40 
Newborn F, normal 
17 ALFL 23 White FS,remission 1:40 
Newborn M, normal 
C-section 
18 EAC 34 Black FS,remission 1:80 
Newborn M, normal 1:10 
C-section 
19 MLF 28 Black FS,remission 
Newborn M, normal 
signs of muscle disease [32). For example, mothers could have active 
muscle disease and high titers of anti-acetylcholine receptor autoan-
tibodies and deliver normal babies [34) . It has been postulated that 
other factors, i.e., alpha-fetoprotein [33) or thymus [35), may modu-
late the expression of neonatal myasthenia gravis. In autoimmune 
thyroid diseases, maternal autoantibodies may cause hyper- or hypo-
thyroidism [38,39). 
In the present study of 19 mother/neonate pairs, in whom the 
mother had well documented FS, all babies were born with clini-
cally normal skin. These findings confirm the results published by 
Proenca et al [17). One baby was born with Down's syndrome and 
multiple congenital abnormalities and died on the second day oflife. 
The mother of this neonate was 48 years of age and had FS for 
several years. Two FS mothers carried two pregnancies to term, 
delivering healthy newborns (pairs 5 and 15, and 8 and 14). The 
results of this investigation show that maternal autoantibodies of 
the IgG4 subclass were predominant in the sera of mothers with FS. 
These findings duplicate our early studies [7). The majority of neo-
nates did not show FS autoantibodies in their cord sera (10/19) or 
bound to their skin (12/17). In the 9 cases where the baby's cord sera 
1: 10 nd + 
1: 20 
1:80 ++ +++ 
1:20 
1: 40 ++ ++ 
1:10 
1:40 ++ +++ 
1 :40 ++ ++ 
1 :40 ++ ++ 
1:80 ++ ++ 
1: 10 
showed a low titer of FS autoantibodies, there was no correlatiOn 
between this finding and weakly positive direct IF of neonatal skin. 
The absence of clinical disease in the majority of newborns could 
be due to either the absence, or negligible titers, of FS autoantibod-
ies in the fetal circulation, which are known to be pathogenic [6 - S), 
or the lack of reactive antigens on the fetal epidermis. The second 
possibility seems to be unlikely, as it is known that neonatal epider-
mis contains FS antigens, as shown by indirect IF studies in several 
publications [6 - 8,21,22) . Moreover, the epidermis of five neonates 
showed weak epidermal ICS staining by direct IF, four of whom 
also exhibited low titers « 1 : 20) of FS autoantibodies in the cord 
serum (babies 1,2, 3, and 11), suggesting that the neonate epidermis 
expressed the FS antigens. 
It is possible that the placenta may have limited the passage ofFS 
autoantibodies to the baby by its barrier function [40). Maternal 
immunoglobulins of the IgG class cross the placenta and reach the 
fetal circulation through an active Fe-receptor transport mechanism 
[41). This transport varies according to the IgG subclass involved, 
i.e., IgGI > IgG2 > IgG4 > IgG3 [42) and appears to be regulated 
also by the functional activity of the antibodies, i.e., avidity [43). 
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Table II. Group 1: FS Mothers with Indirect IF Titers Between 
1:160to 1:320 
Pair Maternal Cord Newborn Skin 
Number Autoantibodies Sera Sera (Direct IF) 
IgG 1:320 < 1: 10 + (weak) 
IgG4 1 : 320 1: 10 NO" 
IgG 1 :320 NO 
6 IgG4 1:160 NO 
IgG 1:160 1 : 10 + (weak) 
2 IgG4 1:320 1 :20 + (weak) 
IgG 1:160 NO 
11 IgG4 1 : 320 1 : 10 + (weak) 
3 IgG 1:80 + 
IgG4 1 : 320 1: 10 
IgG 1 :80 
4 IgG4 1:160 
• NO, not done. 
Other transport mechanisms have been described in the placenta 
that may regulate the passage of charged protein molecules [44] . 
This may apply to the passage of autoantibodies of unique isoelectric 
pOint. There is no transplacental passage ofIgM, IgA, IgD, and IgE 
UUmunoglobulins from the mother to the fetus [45]. 
It is also possible that the placenta may function as an immunoad-
horbent of undesirable antibodies, as suggested by Swinburne [46]. It 
as been shown that placenta contains desmosomal organelles [47]; 
however, it is unknown at present if they contain immunoreactive 
DG-l. Those FS autoantibodies that overflow the "placental im-
munoadsorbent" may reach the fetal circulation. Once these low-
~lter autoantibodies diffuse out of the circulation they will be readily 
Ound by the neonate squamous epithelial tissues and produce a 
weak positive staining of the epidermal ICS by direct IF. Our studies 
would suggest that in FS the placenta appears to playa crucial role in 
mo~ulating the expression of disease in the neonate. 
F Finally, this study also suggests that the etiologic agent triggering 
. S, If I11fectious, does not appear to harm the neonate. Further work 
IS needed to document the incidence of FS in children born to 
mothers with active disease. HLA haplotypes of the family and 
exposure to risk factors will be extremely important in these future 
s~udies. HLA studies in FS show that patients carry a susceptibility to 
t e DR1 Dw20 gene and lack a protective DQw2 gene, present in 
nor~al relatives [48]. Further, a recent case-control study carried 
~Ut 111 the Hospital do Penfi.go in Goiania (state of Goias, Brazil) 
emonstrates that exposure to black fly bites causes a fourfold in-
'~rease in the chance of developing FS in farmers exposed to this risk 
[actor [49] . 
Table III 
~. Group 2: FS Mothers with Indirect IF Titers of 1 : 80 
Pair Maternal Cord Newborn Skin Number Autoantibodies Sera Sera (Direct IF) 
-----7 IgG 1: 80 1 : 40 IgG4 1:80 1:40 NO" 
8 IgG 1: 80 IgG4 1:80 
9 IgG 1 : 80 IgG4 1:80 
14 IgG 1:80 IgG4 1:40 1 : 10 
13 IgG 1 :40 
18 IgG4 1 :80 1: 20 IgG 1:80 1 : 10 
----
IgG4 1:80 1 : 10 
• NO, not done. 
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Table IV. Group 3: FS Mothers with Indirect IF Titers of 
1 : 40 or Lower 
Pair Maternal Cord Ncwborn Skin 






























1: 10 NO 
• NO, not done. 
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